Registration - In-house Corporation

Teva Canada Limited / Teva Canada Limitee / Michael Sine, General Manager

Registration Information

In-house Corporation name: Teva Canada Limited / Teva Canada Limitee
Previous in-house corporation names
Responsible Officer Name: Michael Sine, General Manager
Responsible Officer Change History
Initial registration start date: 2009-01-13
Registration status: Active
Registration Number: 952865-235321

Associated Communications

Total Number of Communication Reports: 100

Monthly communication reports in the last 6 months: 0

Version 2 of 36 (2010-11-15 to 2011-04-11)

Registration versions:

Version 2 of 36 (2010-11-15 to 2011-04-11)

Lobbying Information

Subject Matters

Health
Industry
Intellectual Property
Science and Technology

Subject matters added through a monthly communication report

International Trade

Subject Matter Details

Policies or Program

Health Canada regarding the development and implementation of an approval pathway for Subsequent Entry Biologics (SEBs).
Health Canada regarding the modernization of the Food and Drug Act (formerly Bill C-51) with respect to the development and implementation of a Progressive Licensing Framework for pharmaceuticals
Industry Canada's Science and Technology strategy regarding the need for a balanced Intelectual Property regime and the important role competition plays in encouraging innovation (Mobilizing Science and Technology to Canada's Advantage -- 2007)

Regulation

Industry Canada regarding the need to restore balance to the Patented Medicines (Notice of Compliance) Regulations with respect to pharmaceuticals and address operational concerns including: lack of finality to proceedings under the Regulations and lack of disincentives to discourage abuse of the Regulations.

Communication Techniques

Written communication
Oral communication

Government Institutions

Finance Canada (FIN)
Health Canada (HC)
House of Commons
Industry Canada
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

Government institutions added through a monthly communication report

Foreign Affairs and International Trade Canada (DFAITC)

In-house Corporation Details

Description of activities

PHARMACEUTICAL COMPANY Manufacturing and distribution of Generic Prescription Pharmaceuticals Products

Responsible officer name and position during the period of this registration

Barry Fishman, President & Chief Executive Officer

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
30 Novopharm Court
Toronto, ON M1B 2K9
Canada

Telephone number: 416-291-8888

Parent Company Information

Teva
- 5 Basel St.
  Petach Tikva 49131
  Israel

Subsidiary Beneficiary Information

Teva Canada Limited / Teva Canada Limitee does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Terry Creighton, VP Government Affairs | No public offices held
Barry Fishman, President & Chief Executive Officer | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Andrew van der Gugten, VP, Government Affairs & Market Access | No public offices held
David Windross, VP, External Affairs | No public offices held

Teva Canada Limited/Teva Canada Limitee

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Teva Canada Limited/Teva Canada Limitee	2010-11-15	current
Teva Novopharm	2009-01-13	2009-09-03

Teva Canada Limited / Teva Canada Limitee

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Michael Sine	2022-07-26	Current
Christine Poulin	2018-04-01	2022-07-26
Douglas Sommerville	2014-01-01	2018-04-01
Barry Fishman	2009-01-13	2014-01-01

Michael Sine, General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-100 of 100

Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-11-09
Posted date: 2021-12-14
Communication number: 235321-517268 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies, Health Canada | Health Canada (HC)
- Eric Belair, Associate Assistant Deputy Minister | Strategic Policy Branch, Health Canada | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-11-08
Posted date: 2021-12-14
Communication number: 235321-517263 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Darryl Patterson, Director General | Biomanufacturing Strategy Implementation Team | Innovation, Science and Economic Development Canada (ISED)
- Rione Novak, Director | Biomanufacturing Strategy Implementation Team | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry
Communication date: 2021-08-17
Posted date: 2021-09-14
Communication number: 235321-513975 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-07-28
Posted date: 2021-08-12
Communication number: 235321-512684 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry
Communication date: 2021-04-09
Posted date: 2021-05-15
Communication number: 235321-503601 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steve Verheul, Assistant Deputy Minister | Trade Policy and Negotiation | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade
Communication date: 2020-11-12
Posted date: 2020-12-15
Communication number: 235321-489361 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
- David Lee, Chief Regulatory Officer | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2020-11-09
Posted date: 2020-12-15
Communication number: 235321-489360 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2020-11-06
Posted date: 2020-12-15
Communication number: 235321-489363 (amended from 235321-489359) View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Amanda Woodley, Special Assistant (Policy) Assistant (Parliamentary Secretary) | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Economic Development
Communication date: 2020-11-03
Posted date: 2020-12-15
Communication number: 235321-489362 (amended from 235321-489358) View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stefania Trombetti, Assistant Deputy Minister | Regulatory Operations and Enforcement Branch | Health Canada (HC)
- Stephen Lucas, Deputy Minister | Health Canada (HC)
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry, International Trade, Government Procurement
Communication date: 2020-07-14
Posted date: 2020-08-15
Communication number: 235321-479354 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
- Stefania Trombetti, Assistant Deputy Minister | Regulatory Operations and Enforcement Branch | Health Canada (HC)
- Kendal Weber, Assistant Deputy Minister | Strategy Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry, International Trade, Government Procurement
Communication date: 2020-07-03
Posted date: 2020-08-15
Communication number: 235321-479353 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ryan Dunn, Chief of Staff | Minister Bains' office | Innovation, Science and Economic Development Canada (ISED)
- Bianca Hossain, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development
Communication date: 2020-02-11
Posted date: 2020-03-16
Communication number: 235321-467046 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Monique Lugli, Chief of Staff | Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Economic Development
Communication date: 2019-06-27
Posted date: 2019-07-15
Communication number: 235321-456756 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jason Easton, Chief of Staff | Small Business and Export Promotion | Innovation, Science and Economic Development Canada (ISED)
- Ajandan Siviam, Advisor (Ontario) | Small Business and Export Promotion | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development
Communication date: 2019-05-09
Posted date: 2019-06-15
Communication number: 235321-455521 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
- Amanda Woodley, Policy Advisor | Innovation Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development
Communication date: 2019-05-08
Posted date: 2019-06-15
Communication number: 235321-455501 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Celia Lourenco, Director General | Biologics and Genetic Therapies Division (BGDT) | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2019-04-23
Posted date: 2019-05-15
Communication number: 235321-451085 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Shaun Chen, Member of Parliament | Scarborough North | House of Commons
Subject Matter of the communication: Health, Industry, Economic Development
Communication date: 2018-05-25
Posted date: 2018-06-15
Communication number: 235321-427815 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ginette Petitpas Taylor, Minister of Health | Health Canada (HC)
- Genevieve Hinse, Chief of Staff | Office of the Minister of Health | Health Canada (HC)
- Kathryn Nowers, Director of Policy | Office of the Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2018-04-18
Posted date: 2018-05-15
Communication number: 235321-425313 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philpott Jane, Minister, Indigenous Services | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2017-12-01
Posted date: 2018-02-13
Communication number: 235321-419370 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mary Ng, Member of Parliament | Markham-Thornhill | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2017-09-26
Posted date: 2017-10-16
Communication number: 235321-409180 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Loris Mirella, Director - Intellectual Property Trade Policy | Global Affairs Canada (GAC)
- Cary Seipp, Senior Trade Policy Officer | Global Affairs Canada (GAC)
Subject Matter of the communication: Intellectual Property
Communication date: 2017-09-25
Posted date: 2017-10-16
Communication number: 235321-409018 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jane Philpott, Minister, Indigenous Services | Indigenous and Northern Affairs Canada | House of Commons
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2017-09-25
Posted date: 2017-10-16
Communication number: 235321-409007 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2017-05-11
Posted date: 2017-06-15
Communication number: 235321-403276 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Shaun Govender, Special Assistant - Regional Economic Development | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
- Parvinder Sachdeva, Policy Advisor | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
- Navdeep Bains, Minister of Innovation, Science and Economic Development | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
- David McFarlane, Director of Policy | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2016-11-16
Posted date: 2016-12-15
Communication number: 235321-389551 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2016-10-12
Posted date: 2016-11-15
Communication number: 235321-387670 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Anne Lamar, Assistant Deputy Minister | Regulatory Operations and Regions Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2016-07-14
Posted date: 2016-08-15
Communication number: 235321-382128 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
- Ginette Tognet, Director | Regulatory Affairs & Outreach | Patented Medicine Prices Review Board (PMPRB)
- Jarrett Todd, Regulatory Officer | Patented Medicine Prices Review Board (PMPRB)
- Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2016-06-07
Posted date: 2016-07-15
Communication number: 235321-381091 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2016-05-31
Posted date: 2016-06-15
Communication number: 235321-378846 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Don Davies, Member of Parliament | House of Commons
- Deborah Schulte, Member of Parliament | House of Commons
- Hursh Jaswal, Special Assistant | Immigration, Refugees and Citizenship Canada (IRCC)
- Lindsay Hunter, Ontario Regional Desk & Policy Advisor | Prime Minister's Office (PMO)
- Jamie Kippen, Ontario Regional Desk & Policy Advisor | Prime Minister's Office (PMO)
- Dev Saxena, Senior Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
- David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
- Kathryn Nowers, Policy Advisor / Conseillère en politiques | Health Canada (HC)
- Len Webber, Member of Parliament | House of Commons
- Terence Scheltema, Member's Assistant | House of Commons
- Bill Casey, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, International Trade, Economic Development
Communication date: 2016-05-12
Posted date: 2016-06-15
Communication number: 235321-378909 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2016-02-11
Posted date: 2016-03-15
Communication number: 235321-371039 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Jane Philpott, Minister of Health | Office of the Minister | Health Canada (HC)
- Chrystia Freeland, Minister of International Trade | Office of the Minister | Global Affairs Canada (GAC)
- Brian Clow, Chief of Staff | Office of the Minister | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2015-12-22
Posted date: 2016-01-15
Communication number: 235321-366022 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Fast, Minister of International Trade | Foreign Affairs, Trade and Development Canada
- Bruce Christie, Chief Air Negotiator/Director General | Foreign Affairs, Trade and Development Canada
- Andrea van Vugt, Chief of Staff | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Intellectual Property, International Trade, Economic Development
Communication date: 2015-09-29
Posted date: 2015-10-15
Communication number: 235321-362377 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Idee Inyangudor, Director of Policy and Stakeholder Relations | Office of the Minister of International Development | Foreign Affairs, Trade and Development Canada
- Candice Baetz, Policy Advisor | Office of the Minister of International Development | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Health
Communication date: 2015-07-21
Posted date: 2015-08-15
Communication number: 235321-359427 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gloria Wiseman, Director, Human Development and Gender Equality | Global Health Division | Foreign Affairs, Trade and Development Canada
- Adrijana Corluka, Senior Policy Analyst | Global Health Division | Foreign Affairs, Trade and Development Canada
- Christine Harmston, Manager, International Affairs | Multilateral Relations Division | Foreign Affairs, Trade and Development Canada
- Susan Pierce, Director, Non-Insured Health Benefits Program | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2015-07-20
Posted date: 2015-08-15
Communication number: 235321-359642 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Terrie Romano, Consul - Economic Affairs Ontario | Consulate of Canada | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2015-05-21
Posted date: 2015-06-15
Communication number: 235321-356041 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Barbara Moran, Director, Controlled Substances and Tobacco Directorate | Healthy Environments and Consumer Safety Branch | Health Canada (HC)
- Andrea van Vugt, Chief of Staff | Minister of International Trade | Foreign Affairs, Trade and Development Canada
- Carolyn Bennett, Member of Parliament | House of Commons
- David von Meyenfeldt, Director of Policy | Office of the Minister of State (Sport) | Canadian Heritage (PCH)
- Lois Brown, Member of Parliament | MP, Newmarket | House of Commons
- Chris Lydon, Chief of Staff | Office of the Minister of Labour | Employment and Social Development Canada (ESDC)
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2015-03-27
Posted date: 2015-04-15
Communication number: 235321-350859 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John McCallum, Member of Parliament | House of Commons
- Denis Martel, Director | Industry Canada
- Francois Desmarais, Senior Policy Advisor | Industry Canada
- Paul Calandra, Member of Parliment | House of Commons
- Hedy Fry, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Economic Development
Communication date: 2015-03-26
Posted date: 2015-04-15
Communication number: 235321-350857 (amended from 235321-350834) View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bill Hawkins, Chief of Staff | Minister of International Trade | Foreign Affairs, Trade and Development Canada
- Kirsten Hillman, Associate Assistant Deputy Minister | Trade Agreements and Negotiations | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2014-10-27
Posted date: 2014-11-15
Communication number: 235321-338274 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Denis Martel, Director | Industry Canada
Subject Matter of the communication: Industry, International Trade, Economic Development
Communication date: 2014-10-06
Posted date: 2014-11-15
Communication number: 235321-338313 (amended from 235321-338308) View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Loris Mirella, Deputy Director - Intellectual Property Enforcement | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2014-09-08
Posted date: 2014-10-15
Communication number: 235321-335538 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Calandra, MP Stouffville, Parliamentary Secretary | PM and Intergovernmental Affairs | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Economic Development
Communication date: 2014-08-19
Posted date: 2014-09-15
Communication number: 235321-333202 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Erin O'Toole, MP Durham, Parliamentary Secretary | Minister of International Trade | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Economic Development
Communication date: 2014-08-18
Posted date: 2014-09-15
Communication number: 235321-333203 (amended from 235321-333197) View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Calandra, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2014-03-12
Posted date: 2014-04-15
Communication number: 235321-321673 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christian Carswell, Deputy Director & Senior Business Advisor, Life Sciences | Cleantech, Infrastructure and Life Sciences Practices Division | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2014-01-24
Posted date: 2014-02-15
Communication number: 235321-315539 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Director | Pharmaceutical Sector Directorate | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2013-10-21
Posted date: 2013-11-15
Communication number: 235321-302441 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frédérique B Delaprée, Trade Policy Officer | Intellectual Property Trade Policy Division | Foreign Affairs, Trade and Development Canada
- Loris Mirella, Deputy Director - Intellectual Property Enforcement | Intellectual Property Trade Policy Division | Foreign Affairs, Trade and Development Canada
- Patrick Blanar, Policy Analyst | Marketplace Framework Policy Branch | Industry Canada
- Lynn McDonald, Director | Intellectual Property Trade Policy Division | Foreign Affairs, Trade and Development Canada
- Daniel Meester, Policy Analyst | POLICY RESEARCH AND ECONOMIC ANALYSIS DIVISION | Public Health Agency of Canada (PHAC)
- Dean Foster, Senior Trade Policy Officer | Intellectual Property Trade Policy Division | Foreign Affairs, Trade and Development Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2013-09-17
Posted date: 2013-10-15
Communication number: 235321-296271 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Loris Mirella, Deputy Director - Intellectual Property Enforcement | Intellectual Property Trade Policy Division | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Intellectual Property, International Trade, Economic Development
Communication date: 2013-08-27
Posted date: 2013-09-15
Communication number: 235321-289996 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Daniel Meester, Policy Analyst | POLICY RESEARCH AND ECONOMIC ANALYSIS DIVISION | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2013-07-21
Posted date: 2013-08-15
Communication number: 235321-285950 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mirella Loris, Deputy Director - Intellectual Property Enforcement | Intellectual Property Trade Policy Division | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2013-07-20
Posted date: 2013-08-15
Communication number: 235321-285949 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Denis Martel, Director | Patent Policy Directorate | Industry Canada
- Gerard Peets, Director General | Manufacturing and Life Sciences Branch | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2013-06-07
Posted date: 2013-07-15
Communication number: 235321-280591 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Carmichael, Member of Parliament | House of Commons
- Erin O'Toole, Member of Parliament | House of Commons
- John Weston, Member of Parliament | House of Commons
- Wladyslaw Lizon, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2013-05-23
Posted date: 2013-06-15
Communication number: 235321-275598 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mike Allen, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2013-05-23
Posted date: 2013-06-15
Communication number: 235321-275597 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Barbara J. Sabourin, Director General | Therapeutic Products Directorate (TPD) | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2013-05-03
Posted date: 2013-06-15
Communication number: 235321-276118 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Assistant Deputy Minister | Industry Sector | Industry Canada
- John Knubley, Deputy Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-11-19
Posted date: 2012-12-15
Communication number: 235321-249811 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bernard Trottier, Member of Parliament | House of Commons
- Patrick Brown, Member of Parliament | House of Commons
- Nancy Ruth, Senator | Senate of Canada
- Phil McColeman, Member of Parliament | House of Commons
- Rob Merrifield, Member of Parliament | House of Commons
- Devinder Shorey, Member of Parliament | House of Commons
- Corneliu Chisu, Member of Parliament | House of Commons
- Chungsen Leung, Member of Parliament | House of Commons
- Stella Ambler, Member of Parliament | House of Commons
- Terence Young, Member of Parliament | House of Commons
- Randy Hoback, Member of Parliament | House of Commons
- Ted Opitz, Member of Parliament | House of Commons
- Rick Norlock, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-10-02
Posted date: 2012-11-16
Communication number: 235321-245693 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christian Paradis, Minister of Industry | Industry Canada
- Sean O'Leary, Policy Advisor | Office of the Minister | Industry Canada
- Margaux Stastny, Director of Communications | Office of the Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-08-27
Posted date: 2012-09-15
Communication number: 235321-235130 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Chungsen Leung, Member of Parliament | Willowdale | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-08-21
Posted date: 2012-09-15
Communication number: 235321-234931 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Carmichael, Member of Parliament - Don Valley West | Industry Committee and Ethics Committee | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-08-20
Posted date: 2012-09-15
Communication number: 235321-234929 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- PAUL CALANDRA, MP-OAK RIDGES-MARKHAM | PARLIAMENTARY SECRETARY TO THE MIN. OF CDN HERITAGE OFFICIAL LANGUAGE | Canadian Heritage (PCH)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-07-30
Posted date: 2012-08-22
Communication number: 235321-234349 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Baird, Minister of Foreign Affairs | Foreign Affairs and International Trade Canada (DFAITC)
- Oren Cainer, Senior Policy Advisor | Office of the Minister of Foreign Affairs | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-07-23
Posted date: 2012-08-15
Communication number: 235321-231969 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steve Verheul, Chief Negotiator (Canada-European Union) | Trade Policy and Negotiations Branch | Foreign Affairs and International Trade Canada (DFAITC)
- Marie-France Paquet, Director of Operations | Economic and Regional Development Policy | Privy Council Office (PCO)
- Andrea van Vugt, Policy Advisor | Foreign Affairs, Trade and International Development | Prime Minister's Office (PMO)
- Melanie Raymond, Senior Policy Officer | Economic and Regional Development Policy | Privy Council Office (PCO)
- Karen Kennedy, Deputy Director | Intellectual Property Trade Policy Division (TMI) | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-07-06
Posted date: 2012-07-19
Communication number: 235321-230342 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Ailish Campbell, Director General | Manufacturing and Life Sciences Branch | Industry Canada
- Vimla Ramlall, Policy Analyst | Life Science Industries Branch | Industry Canada
- Mark A. Schaan, D.Phil, Director, Pharmaceutical Policy | Life Science Industries Branch | Industry Canada
- Lise-Ann Jackson, Senior Advisor - Policy and Stakeholder Relations | Foreign Affairs and International Trade Canada (DFAITC)
- Philip Jennings, Associate Assistant Deputy Minister, Industry Sector | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-07-05
Posted date: 2012-07-19
Communication number: 235321-230357 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Glenda Yeates, Deputy Minister | Health Canada (HC)
- Scott Tessier, Chief of Staff | Office of the Minister | Health Canada (HC)
- Paul Glover, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
- Colin Carrie, Parliamentary Secretary to the Minister of Health | Office of the Minister | Health Canada (HC)
- Leona Aglukkaq, Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Consumer Issues
Communication date: 2012-03-14
Posted date: 2012-04-16
Communication number: 235321-217148 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christian Paradis, Minister of Industry | Industry Canada
- Pierre-Claude Nolin, Senator | Senate of Canada
- David Angus, Senator | Senate of Canada
- Steven Blaney, Minister of Veterans Affairs | Veterans Affairs Canada (VAC)
- Jacques Gourde, Member of Parliament | House of Commons
- Gyslain Maltais, Senator | Senate of Canada
- Leo Housakos, Senator | Senate of Canada
- Pierre-Hugues Boisvenu, Senator | Senate of Canada
- Josee Verner, Senator | Senate of Canada
- Suzanne Fortin-Dupplessis, Senator | Senate of Canada
- Denis Lebel, Minister of Transport and Minister of State | Canadian Economic Development | Transport Canada (TC)
- Judith Seidman, Senator | Senate of Canada
- Michel Rivard, Senator | Senate of Canada
- Andree Champagne, Senator | Senate of Canada
- Claude Carignan, Senator | Senate of Canada
- Jacques Demers, Senator | Senate of Canada
- Patrick Brazeau, Senator | Senate of Canada
- Maxime Bernier, Minister of State | Small Business and Tourism | Industry Canada
- Larry Smith, Senator | Senate of Canada
- Jean-Guy Dagenais, Senator | Senate of Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-03-07
Posted date: 2012-04-16
Communication number: 235321-217168 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2012-03-02
Posted date: 2012-04-16
Communication number: 235321-217147 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Policy Advisor | Office of the Minister | Industry Canada
- Christian Paradis, Minister of Industry | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-02-02
Posted date: 2012-03-16
Communication number: 235321-212522 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stella Ambler, Member of Parliament | House of Commons
- Brad Butt, Member of Parliament | House of Commons
- Wladyslaw Lizon, Member of Parliament | House of Commons
- Bal Gosal, Minister of State (Sport) | Canadian Heritage (PCH)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-01-25
Posted date: 2012-02-16
Communication number: 235321-205393 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rathika Sitsabaiesan, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-01-20
Posted date: 2012-02-22
Communication number: 235321-209015 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Carmichael, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-01-19
Posted date: 2012-02-22
Communication number: 235321-209016 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Harris, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-01-18
Posted date: 2012-02-22
Communication number: 235321-209014 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Calandra, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-01-13
Posted date: 2012-02-22
Communication number: 235321-209013 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Corneliu Chisu, Member of Parliament | House of Commons
- John McCallum, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-01-12
Posted date: 2012-02-22
Communication number: 235321-209012 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Associate Assistant Deputy Minister | Industry Canada
- John Connell, Associate Assistant Deputy Minister | Industry Canada
- Simon Kennedy, Senior Associate Deputy Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-01-12
Posted date: 2012-02-16
Communication number: 235321-205394 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Adler, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2012-01-10
Posted date: 2012-02-22
Communication number: 235321-209011 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kellie Leitch, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Budget
Communication date: 2012-01-03
Posted date: 2012-02-22
Communication number: 235321-209017 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kirsty Duncan, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-12-19
Posted date: 2012-02-22
Communication number: 235321-209010 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Joe Oliver, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-12-16
Posted date: 2012-02-22
Communication number: 235321-209009 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Chris Alexander, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-12-10
Posted date: 2012-02-22
Communication number: 235321-209008 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Patented Medicine Prices Review Board (PMPRB)
- Mary Catherine Lindberg, Chairperson | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2011-12-09
Posted date: 2012-01-16
Communication number: 235321-201449 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Corneliu Chisu, Member of Parliament | House of Commons
- Terence Young, Member of Parliament | House of Commons
- Gord Brown, Member of Parliament | House of Commons
- Bob Dechert, Member of Parliament | House of Commons
- Brad Butt, Member of Parliament | House of Commons
- Chungsen Leung, Member of Parliament | House of Commons
- Colin Carrie, Member of Parliament | House of Commons
- Patrick Brown, Member of Parliament | House of Commons
- Devinder Shory, Member of Parliament | House of Commons
- Bal Gosal, Minister of State (Sport) | Canadian Heritage (PCH)
- Bernard Trottier, Member of Parliament | House of Commons
- Brian Storseth, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-12-06
Posted date: 2012-01-16
Communication number: 235321-201448 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Policy Advisor | Office of the Minister of Industry | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-12-06
Posted date: 2012-01-16
Communication number: 235321-201447 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John McKay, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-11-25
Posted date: 2012-02-22
Communication number: 235321-209007 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Associate Assistant Deputy Minister | Industry Canada
- John Connell, Associate Assistant Deputy Minister | Industry Canada
- Simon Kennedy, Senior Associate Deputy Minister | Industry Canada
- Richard Dicerni, Deputy Minister | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-11-03
Posted date: 2011-12-16
Communication number: 235321-199960 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rudy Husny, Press Secretary | Office of the Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Ed Fast, Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-10-24
Posted date: 2011-11-16
Communication number: 235321-192265 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steve Verheul, Chief Negotiator (Canada-European Union) | Trade Policy and Negotiations Branch | Foreign Affairs and International Trade Canada (DFAITC)
- Ana Renart, Deputy Chief Negotiator (Canada-European Union) | Trade Policy and Negotiations Branch | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-10-11
Posted date: 2011-11-16
Communication number: 235321-192264 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Calandra, Member of Parliament | Oak Ridges—Markham | House of Commons
Subject Matter of the communication: Industry, International Trade, Regional Development
Communication date: 2011-08-09
Posted date: 2011-09-16
Communication number: 235321-185526 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrew Saxton, Member of Parliament | House of Commons
- Blaine Calkins, Member of Parliament | House of Commons
- Ron Cannan, Member of Parliament | House of Commons
- Leon Benoit, Member of Parliament | House of Commons
- Gerry Breitkreuz, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-03-08
Posted date: 2011-04-16
Communication number: 235321-170345 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Judy Sgro, Member of Parliament | House of Commons
- Alan Tonks, Member of Parliament | House of Commons
- Mauril Belanger, Member of Parliament | House of Commons
- Paul Szabo, Member of Parliament | House of Commons
- Glen Pearson, Member of Parliament | House of Commons
- Anthony Rota, Member of Parliament | House of Commons
- Frank Mahovlich, Senator | Senate of Canada
- Carolyn Bennett, Member of Parliament | House of Commons
- John McCallum, Member of Parliament | House of Commons
- Yasmin Ratansi, Member of Parliament | House of Commons
- Mark Holland, Member of Parliament | House of Commons
- Luch Durante, Special Assistant, Ontario | Office of the Leader of the Opposition | House of Commons
- Art Eggleton, Senator | Senate of Canada
- Bonnie Crombie, Member of Parliament | House of Commons
- Rob Oliphant, Member of Parliament | House of Commons
- Michelle Simson, Member of Parliament | House of Commons
- Bryon Wilfert, Member of Parliament | House of Commons
- Derek Lee, Member of Parliament | House of Commons
- Maria Minna, Member of Parliament | House of Commons
- Andrew Kania, Member of Parliament | House of Commons
- David Smith, Senator | Senate of Canada
- Ken Dryden, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-03-02
Posted date: 2011-12-07
Communication number: 235321-170346 (amended from 235321-170344) View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Trade Negotiations Branch | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-15
Posted date: 2011-03-16
Communication number: 235321-166547 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dave Forestell, Policy Advisor | Policy | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-15
Posted date: 2011-03-16
Communication number: 235321-166546 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Laanemets, Special Assistant | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Liam O'Brien, Director of Policy | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Christopher Crawford, Special Assistant | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Geoffrey Leblovic, Special Assistant | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-15
Posted date: 2011-03-16
Communication number: 235321-166545 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Derek Lee, Member of Parliament | House of Commons
- Kirsty Duncan, Member of Parliament | House of Commons
- Bonnie Crombie, Member of Parliament | House of Commons
- Bryon Wilfert, Member of Parliament | House of Commons
- Judy Sgro, Member of Parliament | House of Commons
- Alan Tonks, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-15
Posted date: 2011-03-16
Communication number: 235321-166544 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bob Rae, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-11
Posted date: 2011-03-16
Communication number: 235321-165928 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mike Wallace, Member of Parrliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-08
Posted date: 2011-03-16
Communication number: 235321-165888 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Terence Young, Member of Parliament | House of Commons
- Christina Noble, Legislative Assistant | Office of the Minister | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-08
Posted date: 2011-03-16
Communication number: 235321-165887 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Laanemets, Special Assistant | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Colin Carrie, Parlimentary Secretary to the Minister of Health | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-02-08
Posted date: 2011-03-16
Communication number: 235321-165885 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Geoffrey Leblovic, Special Assistant | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Peter Van Loan, Minister of International Trade | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Sandra Buckler, Chief of Staff | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Liam O'Brien, Director of Policy | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Adam Church, Senior Policy Advisor | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Paul Laanemets, Special Assistant | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
- Steve Verheul, Chief Trade Negotiator (Canada-European Union) | Trade Policy and Negotiations Branch | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2010-11-22
Posted date: 2011-03-16
Communication number: 235321-169035 (amended from 235321-161160) View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Elie Salibi, Policy Advisor | Office of the Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2009-10-27
Posted date: 2009-11-23
Communication number: 235321-130434 Associated registration not available
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- richard dicerni, deputy minister | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2009-01-14
Posted date: 2009-03-11
Communication number: 235321-93726 View associated registration
Teva Canada Limited
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leona Aglukkaq, minister of health | Health Canada (HC)
- leah canning, policy advisor | office of the minister | Health Canada (HC)
- meena ballantyne, assis deputy minister | health products and foos branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2009-01-14
Posted date: 2009-03-11
Communication number: 235321-93719 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Teva Canada Limited / Teva Canada Limitee / Michael Sine, General Manager

Registration Information

Associated Communications

Version 2 of 36 (2010-11-15 to 2011-04-11)

Version 2 of 36 (2010-11-15 to 2011-04-11)

Subject Matters

Subject matters added through a monthly communication report

Subject Matter Details

Policies or Program

Regulation

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties